Vertex Pharmaceuticals IncorporatedVRTXNASDAQ
LOADING
|||
Revenue Scaling
Trending higher, above historical average, strong compound growth.
Left:
||||
Total revenue from sales of goods and services
Latest
$11.02B
↑ 97% above average
Average (9y)
$5.60B
Historical baseline
Range
High:$11.02B
Low:$1.03B
CAGR
+30.1%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $11.02B | +11.7% |
| 2023 | $9.87B | +10.5% |
| 2022 | $8.93B | +17.9% |
| 2021 | $7.57B | +22.1% |
| 2020 | $6.21B | +49.1% |
| 2019 | $4.16B | +36.6% |
| 2018 | $3.05B | +22.5% |
| 2017 | $2.49B | +46.2% |
| 2016 | $1.70B | +64.9% |
| 2015 | $1.03B | - |